Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; Moderna’s Asia expansion
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; [...]
Fierce Pharma Asia—Lilly, Innovent’s I-O implications; Novartis’ India job cuts; [...]
Organon CEO pins high hopes on upcoming Humira biosimilar launch [...]
GSK launches trade secrets case against former employee, ordering data [...]
Lilly’s tirzepatide doesn’t necessarily top diabetes rivals Jardiance and Ozempic, [...]
As Johnson & Johnson fights for bankruptcy ploy in talc [...]
After FDA’s surprising about-face, Acadia revives Nuplazid’s expansion bid with [...]
Thermo Fisher dishes up $40M for Pennsylvania facility expansion, creating [...]
ASCO GU: Amgen’s Lumakras posts encouraging results in pancreatic cancer, [...]
Pfizer and Regeneron led pharma’s sales growth in Q4 while [...]
Novartis plots 400 job cuts in India after striking sales [...]